- Badrani, Jana H;
- Strohm, Allyssa N;
- Lacasa, Lee;
- Civello, Blake;
- Cavagnero, Kellen;
- Haung, Yung-An;
- Amadeo, Michael;
- Naji, Luay H;
- Lund, Sean J;
- Leng, Anthea;
- Kim, Hyojoung;
- Baum, Rachel E;
- Khorram, Naseem;
- Mondal, Monalisa;
- Seumois, Grégory;
- Pilotte, Julie;
- Vanderklish, Peter W;
- McGee, Heather M;
- Doherty, Taylor A
Innate lymphoid cells (ILC) promote lung inflammation in asthma through cytokine production. RNA-binding proteins (RBPs) are critical post-transcriptional regulators, although less is known about RBPs in ILC biology. Here, we demonstrate that RNA-binding motif 3 (RBM3) is highly expressed in lung ILCs and is further induced by alarmins TSLP and IL-33. Rbm3-/- and Rbm3-/-Rag2-/- mice exposed to asthma-associated Alternaria allergen develop enhanced eosinophilic lung inflammation and ILC activation. IL-33 stimulation studies in vivo and in vitro show that RBM3 suppressed lung ILC responses. Further, Rbm3-/- ILCs from bone marrow chimeric mice display increased ILC cytokine production suggesting an ILC-intrinsic suppressive function of RBM3. RNA-sequencing of Rbm3-/- lung ILCs demonstrates increased expression of type 2/17 cytokines and cysteinyl leukotriene 1 receptor (CysLT1R). Finally, Rbm3-/-Cyslt1r-/- mice show dependence on CysLT1R for accumulation of ST2+IL-17+ ILCs. Thus, RBM3 intrinsically regulates lung ILCs during allergen-induced type 2 inflammation that is partially dependent on CysLT1R.